Ashley Hall - Nov 12, 2021 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (RPHM)

Role
Chief Development Officer
Signature
/s/ Vineet R. Jindal, Attorney-in-Fact
Stock symbol
RPHM
Transactions as of
Nov 12, 2021
Transactions value $
$0
Form type
4
Date filed
11/15/2021, 06:49 PM
Previous filing
Oct 14, 2021
Next filing
Dec 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPHM Common Stock Award $0 +30K $0.00 30K Nov 12, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPHM Stock Option (right to buy) Award $0 +180K $0.00 180K Nov 12, 2021 Common Stock 180K $8.85 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit award.
F2 1/4 of the shares subject to the stock option vest and become exercisable on October 11, 2022, and the remaining shares vest in equal monthly installments over the subsequent 36 months.